Stratec

SBS.DE Micro Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

€17.76

+1.49% today

52W: €16.36 – €33.10

52W Low: €16.36 Position: 8.4% 52W High: €33.10

🔗 Compare Brokers

Key Metrics

P/E Ratio

13.98x

Price-to-Earnings

Forward P/E

11.41x

Forward Price/Earnings

P/S Ratio

0.83x

Price-to-Sales

EV/EBITDA

8.16x

Enterprise Value/EBITDA

Div. Yield

338%

Annual dividend yield

Market Cap

$215.9M

Market Capitalization

Revenue Growth

-5.4%

YoY Revenue Growth

Profit Margin

5.9%

Net profit margin

ROE

6.57%

Return on Equity

Beta

0.8

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

10,766

Average daily volume

Valuation Analysis

Signal

Undervalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

5 analysts

Avg. Price Target

€28.46

+60.25% upside

Target Range

€23.00 – €34.00

About the Company

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Sector: Healthcare Industry: Medical Devices Country: Germany Employees: 1,420 Exchange: GER